[ad_1]
This measure should accelerate the vaccination efforts of the population in the Old Continent.
The Johnson & Johnson vaccine was approved by the European Medicines Agency (EVA) in mid-March. COVID-19 vaccines, developed by Pfizer / BioNTech, Moderna, and AstraZeneca, have previously been licensed for distribution in the European Union.
The European Union has placed an order with Johnson & Johnson to buy 200 million dollars. vaccine doses with an option to buy another 200 million. dose.
This preparation is not only the first, one dose is enough, it can also be considered in simpler conditions.
The EVA authorized the drug’s distribution, stating that in clinical trials with volunteers in the US, South Africa and South America, the Johnson & Johnson vaccine has been shown to protect against 67% of coronavirus infections. effectiveness.
Several European countries have tightened quarantine measures again in recent days in an attempt to curb the growing incidence of COVID-19, as the pace of vaccination campaigns has been slower than in some other countries, such as the United States. or United Kingdom.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
